Report copyright - Importance of optimal dosing ≥30 mg/kg/d during deferasirox treatment: 2.7-yr follow-up from the ESCALATOR study in patients with β-thalassaemia
Please pass captcha verification before submit form
Please pass captcha verification before submit form